Absolent delivered another quarter with solid numbers across the board.
Xbrane's Q2 results came in ahead of our estimates on revenue and EBIT, but the report reinforces th...
* Sales of SEK 405m, organic decline of ~2% * Adj. EBITA of SEK 23m, and a margin of 5.
Redeye comments on CombinedX's Q2 2026 report, which fell short of our profitability forecast even a...
Safeture’s latest report confirms a continued positive trajectory, posting ARR growth of 13% and sal...
* Sales SEK 247m (+8% vs. ABGSCe), adj. EBIT SEK 14m (vs.
* Sales +1%, adj. EBITA +2% vs. FactSet consensus * Slight beat driven by Finland improving faster a...
Redeye provides an initial comment on the Q2 2026 report from Sdiptech.
Yesterday, 123f released preliminary H1'26 figures, which we regard as a solid print given the ongoi...
* Adj. EBIT SEK 20m, 7% below ABGSCe SEK 21m * Continued sales drag from contract manufacturing * Co...
Redeye provides an initial comment on Nyorda's (formerly Tradedoubler) Q2 2026 report.
Truecaller reported Q2 net sales above our expectations and consensus, driven by a sequential recove...
Redeye provides its initial take on Navigo's Q2 2026 report, which came in above our sales estimate ...
Gapwaves’ Q2 was weak, with net sales 30% below Redeye’s forecast and down 46% y/y.
* Adj. EBITA SEK 253m (-7% vs. ABG, -3% vs. MFN cons) * We expect cons EBITA to come down by 2-3% * ...
The market focused on the revised 2026 sales growth target rather than another quarter of improving ...
The Swedish Government's rejection of Västvind represents a setback for Eolus' offshore option, but ...
Net sales and adjusted EBITA were close to LSEG consensus in Q2.
Redeye provides an update following Senzime’s Q2 2026 report.
Redeye retains its positive view of Vertiseit following the Q2 2026 report.